Loading organizations...
VIC Group develops, manufactures, and distributes a comprehensive portfolio of veterinary pharmaceuticals. Its core capabilities span research and development of innovative animal health solutions, robust production of medications for farm and companion animals, and extensive distribution networks. The company’s offerings include feed additives and specialized products crucial for agricultural productivity and animal well-being.
Established in 1990, VIC Group originated from an ambitious goal to create world-class veterinary pharmaceutical production and logistics within the Commonwealth of Independent States. The initial insight addressed the critical need for high-quality domestic veterinary drugs, aiming to reduce reliance on foreign imports. This mission spurred development of proprietary medications and robust support systems for the agro-industrial complex.
The company serves agricultural producers, providing essential medicines for livestock, and also caters to companion animal owners. VIC Group’s long-term vision focuses on continuous innovation, developing high-quality national veterinary products, and expanding its global export presence. It strives to remain a leading force in animal health, contributing to animal welfare and agricultural efficiency.
VIC Group has 1 tracked investment across 1 company. The latest tracked deal is $5.0M Series A in Octopus Network in September 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 9, 2021 | Octopus Network | $5.0M Series A | Aussie Capital, Autonomy Capital, Bigcoin Capital, Chainridge VC, Digital Currency Group, Elevate Capital, Finance Ventures, Gains Associates, Gate.io, GTA Venture, Jigsaw, Jubi LAB, LCG Ventures, Mayor Capital, Meridian Capital, Move Capital, Netzero Capital, Vestigium, VIC Group, Westorm, Youbi Capital | Debio, Discovol, Myriad Social |